Agenus Inc. 2022 Annual Report 10-K

Agenus Inc.'s 2022 Form 10-K annual report filed with the SEC detailing the company's business operations, financial performance, and strategic direction. The biotech company, traded on Nasdaq Capital Market under ticker AGEN, provides comprehensive disclosure of its research and development activities, intellectual property portfolio, and regulatory compliance status.